▲ BUY
5
/ 10
Conviction
$ Value
$2K
Shares
5,000
Price
$0
Filed
Dec 5
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Watson W. Mark
Title
—
CIK
0001612372
Roles
Director
Transaction Details
Transaction Date
2025-11-17
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
124,125
Footnotes
This Form 4 is being filed late due to delays in receiving EDGAR access codes.
Filing Info
Watson W. Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-17 | VXRT | ▲ | $6K ★ |
| 2025-11-17 | VXRT | ▲ | $2K |
| 2025-07-29 | VXRT | ▲ | $4K |
| 2025-06-13 | VXRT | A | $0 |
| 2025-06-13 | VXRT | A | $0 |
Other Insiders at VXRT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lo Steven
President, Chief Exec Officer
|
— | — | 2026-03-24 |
|
Tucker Sean
SVP, Chief Scientific Officer
|
— | — | 2026-03-28 |
|
Cummings James F.
Chief Medical Officer
|
— | — | 2026-03-28 |
|
Berg Edward B
SVP, General Counsel
|
— | — | 2026-03-24 |
|
Grasman Jeroen Nicolaas
Chief Financial Officer
|
— | — | 2026-03-16 |